within Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EE04_Travoprost;
model Travoprost 
   extends Pharmacolibrary.Drugs.ATC.S.S01EE04;

  annotation(Documentation(
    info ="<html><body><p>Travoprost is a prostaglandin analog used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is administered as an ophthalmic solution and is approved and widely used for ocular hypertension and glaucoma management.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported in healthy adult volunteers following ocular administration.</p><h4>References</h4><ol><li><p>Stahl, E, et al., &amp; Dixon, ER (2017). Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 33(5) 361–365. DOI:<a href=&quot;https://doi.org/10.1089/jop.2016.0133&quot;>10.1089/jop.2016.0133</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28437175/&quot;>https://pubmed.ncbi.nlm.nih.gov/28437175</a></p></li><li><p>Herceg, M, &amp; Noecker, R (2008). Travoprost/timolol fixed combination. <i>Expert opinion on pharmacotherapy</i> 9(6) 1059–1065. DOI:<a href=&quot;https://doi.org/10.1517/14656566.9.6.1059&quot;>10.1517/14656566.9.6.1059</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18377347/&quot;>https://pubmed.ncbi.nlm.nih.gov/18377347</a></p></li><li><p>El-Gendy, MA, et al., &amp; Mortada, ND (2023). Travoprost Liquid Nanocrystals: An Innovative Armamentarium for Effective Glaucoma Therapy. <i>Pharmaceutics</i> 15(3) –. DOI:<a href=&quot;https://doi.org/10.3390/pharmaceutics15030954&quot;>10.3390/pharmaceutics15030954</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36986814/&quot;>https://pubmed.ncbi.nlm.nih.gov/36986814</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Travoprost;
